About conolidine
These outcomes, together with a earlier report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 aid the thought of targeting ACKR3 as a novel approach to modulate the opioid system, which could open new therapeutic avenues for opioid-similar disorders.Scientists feel that blocking this scavenger receptor